Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial-Reference-Cited by-同舟云学术

Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial

Published:2019-03 Issue:3 Volume:19 Page:275-286
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Wedemeyer Heiner,Yurdaydin Cihan,Hardtke Svenja,Caruntu Florin Alexandru,Curescu Manuela G,Yalcin Kendal,Akarca Ulus S,Gürel Selim,Zeuzem Stefan,Erhardt Andreas,Lüth Stefan,Papatheodoridis George V,Keskin Onur,Port Kerstin,Radu Monica,Celen Mustafa K,Idilman Ramazan,Weber Kristina,Stift Judith,Wittkop Ulrike,Heidrich Benjamin,Mederacke Ingmar,von der Leyen Heiko,Dienes Hans Peter,Cornberg Markus,Koch Armin,Manns Michael P

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference30 articles.

1. The hepatitis delta virus: replication and pathogenesis;Sureau;J Hepatol,2016

2. Hepatitis delta virus;Hughes;Lancet,2011

3. A 28-year study of the course of hepatitis delta infection: a risk factor for cirrhosis and hepatocellular carcinoma;Romeo;Gastroenterology,2009

4. Outcome of chronic delta hepatitis in Italy: a long-term cohort study;Niro;J Hepatol,2010

5. Development and evaluation of a baseline-event-anticipation score for hepatitis delta;Calle Serrano;J Viral Hepat,2014

Cited by 143 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis delta virus;Treatment and Management of Tropical Liver Disease;2025

2. The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies;Journal of Clinical and Experimental Hepatology;2024-09

3. Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort;JHEP Reports;2024-08

4. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide;JHEP Reports;2024-08

5. Reply: The causal analysis of missing confounding factors for the association between HDV and specific liver events;Hepatology;2024-07-17